-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GcftB8rvqxxYtpApDcjWn+TzuCYJaLTasg75ARQj14kobGzWd/cVzm7zobsavIEn Q3fEIt0rghAQ+3KWFfFP9Q== 0000014272-03-000020.txt : 20030804 0000014272-03-000020.hdr.sgml : 20030804 20030804155336 ACCESSION NUMBER: 0000014272-03-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030801 FILED AS OF DATE: 20030804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGAL ELLIOT CENTRAL INDEX KEY: 0001202294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 03820709 BUSINESS ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB CO. STREET 2: 345 PARK AVE. CITY: NEW YORK STATE: NY ZIP: 10154 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 sig150.xml X0201 4 2003-08-01 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001202294 SIGAL ELLIOT BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON NJ 08540 0 1 0 0 SVP, Global Clin & Pharm Dev Common Stock, $0.10 par value 2003-08-01 4 F 0 1219 0 D 75024.00 D Common Stock, $0.10 par value 1199.80 I By BMY Savings & Investment Program Shares withheld for payment of taxes upon vesting of restricted stock. Based on a plan statement as of the end of the most recent fiscal quarter. By: /s/ Sonia Vora, Attorney-in-Fact 2003-08-04 EX-24 3 sigal.htm POWER OF ATTORNEY POWER OF ATTORNEY

POWER OF ATTORNEY

 

I, Elliott Sigal, M.D., Senior Vice President, Global Clinical and Pharmaceutical Development of Bristol-Myers Squibb Company, a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung and Sonia Vora, individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions.

IN WITNESS WHEREOF, I have executed this Power of Attorney on this 28th day of August, 2002.

 

 

/s/ Elliott Sigal, M.D., Ph.D.

Elliott Sigal, M.D., Ph.D.

 -----END PRIVACY-ENHANCED MESSAGE-----